The interactions are perpetrated in two directions: (i) IGF/IGF-IR regulates sarcoma matrix effector synthesis, structure/organization, and downstream functions; and (ii) sarcoma matrix effectors modulate IGF/IGF-IR pathway restricted signaling. The gene discussed is IGF1R; the disease is sarcoma.